UnitedHealth Stock News

UnitedHealth Group NYSE: UNH has staged a formidable comeback, with its stock up over 29% in the last 90 days as investors embraced management's aggressive turnaround strategy. This powerful rally has built high expectations, and the market now looks to UnitedHealth Group's third-quarter earnings report on Oct. 28 for the proof needed to sustain the momentum.

UnitedHealth (UNH)'s stock jumped 31% in three months, driven not only by a slight increase in revenue and a high P/E multiple, but also amid mixed signals: a Q2 earnings miss, regulatory scrutiny, and renewed investments in AI. What's behind this volatility?

UnitedHealth's decision to exit 100-plus Medicare Advantage plans was a prudent move. The stock could have significant upside potential as its bottom line improves.

An artificial intelligence system from UnitedHealth Group has reportedly sped up prior authorization requests and reduced medical claims denials “meaningfully” during testing at Minneapolis-based hospital system Allina Health.

"Buying the dip" can be a double-edged sword for investors. Sometimes they can seize the opportunity by purchasing an oversold stock, but other times, that stock is trending lower for a good reason (and just might stay there).

US managed care insurers were trading down this week ahead of earnings season as the release of Medicare ratings and federal tax credit uncertainty appeared to weigh on stock prices. The S&P 500 and S&P Insurance Index similarly declined, falling 1.29% and 7.03%.

UnitedHealth: Bargaining Power And Tariff-Driven Generics Could Improve Margins

Burns Matteson Capital Management, LLC reported a new stake in UnitedHealth Group (UNH -1.45%), acquiring 8,017 shares in the third quarter of 2025, an estimated $2.77 million trade as of the end of the third quarter.